» Articles » PMID: 25193333

β-hydroxybutyrate: Much More Than a Metabolite

Overview
Specialty Endocrinology
Date 2014 Sep 7
PMID 25193333
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

The ketone body β-hydroxybutyrate (βOHB) is a convenient carrier of energy from adipocytes to peripheral tissues during fasting or exercise. However, βOHB is more than just a metabolite, having important cellular signaling roles as well. βOHB is an endogenous inhibitor of histone deacetylases (HDACs) and a ligand for at least two cell surface receptors. In addition, the downstream products of βOHB metabolism including acetyl-CoA, succinyl-CoA, and NAD+ (nicotinamide adenine dinucleotide) themselves have signaling activities. These regulatory functions of βOHB serve to link the outside environment to cellular function and gene expression, and have important implications for the pathogenesis and treatment of metabolic diseases including type 2 diabetes.

Citing Articles

Comprehensive Overview of Ketone Bodies in Cancer Metabolism: Mechanisms and Application.

Liang Z, Deng L, Zhou X, Zhang Z, Zhao W Biomedicines. 2025; 13(1).

PMID: 39857793 PMC: 11760447. DOI: 10.3390/biomedicines13010210.


Exploring the potential of the ketogenic diet in autism spectrum disorder: metabolic, genetic, and therapeutic insights.

Schrickel A, Groeneweg J, Dekeyster E Metab Brain Dis. 2025; 40(1):94.

PMID: 39776279 PMC: 11711257. DOI: 10.1007/s11011-024-01518-1.


Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome.

Borrego-Ruiz A, Borrego J Genes (Basel). 2025; 15(12.

PMID: 39766866 PMC: 11675900. DOI: 10.3390/genes15121599.


Genetically engineered bacteria as inflammatory bowel disease therapeutics.

Zou Z, Zhang X, Zhang Q, Yin B, Zhou Y, Ye B Eng Microbiol. 2024; 4(4):100167.

PMID: 39628589 PMC: 11611042. DOI: 10.1016/j.engmic.2024.100167.


Case report: Ketogenic diet alleviated anxiety and depression associated with insulin-dependent diabetes management.

Winje E, Lake I, Dankel S Front Nutr. 2024; 11:1404842.

PMID: 39539363 PMC: 11557308. DOI: 10.3389/fnut.2024.1404842.


References
1.
New M, Olzscha H, La Thangue N . HDAC inhibitor-based therapies: can we interpret the code?. Mol Oncol. 2012; 6(6):637-56. PMC: 5528347. DOI: 10.1016/j.molonc.2012.09.003. View

2.
Badman M, Kennedy A, Adams A, Pissios P, Maratos-Flier E . A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss. Am J Physiol Endocrinol Metab. 2009; 297(5):E1197-204. PMC: 2781352. DOI: 10.1152/ajpendo.00357.2009. View

3.
Kim D, Rho J . The ketogenic diet and epilepsy. Curr Opin Clin Nutr Metab Care. 2008; 11(2):113-20. DOI: 10.1097/MCO.0b013e3282f44c06. View

4.
Layden B, Angueira A, Brodsky M, Durai V, Lowe Jr W . Short chain fatty acids and their receptors: new metabolic targets. Transl Res. 2012; 161(3):131-40. DOI: 10.1016/j.trsl.2012.10.007. View

5.
Kenyon C . The genetics of ageing. Nature. 2010; 464(7288):504-12. DOI: 10.1038/nature08980. View